NPI registry status
Active
2026 NPPES data Ophthalmology Physician NPI 1275581621 M.D.
Verify on CMS → Michael Gingold, M.D.
Ophthalmology Physician in Farmington, Connecticut.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 22,082 in Ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 847 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
84%
generic claims · 16% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
98.2/100
▲ 15 pts above national avg 83.1 · Exceptional
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Michael Gingold, M.D. reported a CMS MIPS final score of 98.2/100 - above the 83.1 national average - and filed 1,623 Medicare Part D claims in 2023.
- 98.2/100
- MIPS score · +15 vs avg
- 2K
- Part D claims, 2023
- 84%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Michael Gingold, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
98 Top 11% higher than 89% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Michael Gingold, M.D. sits
This provider among ophthalmology physician peers
Across the 9,866 ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Michael Gingold, M.D. writes more Part D claims than 63% of them and scores higher on MIPS quality than 82% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one ophthalmology physician peer from a representative sample of 60; the gold marker is Michael Gingold, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Michael Gingold, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Michael Gingold, M.D.?
High performer (top quartile)Primary specialty
Ophthalmology Physician
Medicare Part D claims
1,623 14% vs specialty avg
MIPS final score
98.2/100 15.1 pts vs avg
Specialty distribution in Connecticut
How Ophthalmology Physician compares to other specialties among Connecticut providers
Medicare quality performance, MIPS
Michael Gingold, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average
- MIPS Final Score
- 98.2/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Ophthalmology Physician) - 98.2/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Michael Gingold, M.D. appears in the CMS NPPES registry as an Ophthalmology Physician provider holding M.D. credentials at 499 FARMINGTON AVE, Farmington, CT, 06032, with a listed phone of (860) 678-0202. NPI 1275581621 was issued on 05/05/2006.
Medicare Part D records for calendar year 2023 show 1,623 prescription claims written by this provider, covering 847 Medicare beneficiaries and totaling roughly $89K in drug spend, split 16% brand-name and 84% generic by claim count, with an opioid prescribing rate of 4.6%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 98.2/100 for the 2023 performance year (Quality 96.4), compared with the national average of 83.1.
Ophthalmology Physician is a mid-sized specialty nationwide, with 22,082 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1275581621 |
|---|---|
| Specialty | Ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 05/05/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
98.1849
Final Score
Avg: 83.1
96.3698
Quality
Reporting: Individual
Hospital and facility affiliations
Facilities where Michael Gingold, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Consulting Ophthalmologists, P.C.
Farmington, CT
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Brand vs generic prescribing mix · Typical
Michael Gingold, M.D. - brand share 16.0%
Ophthalmology Physician average
16% brand-name claims vs 84% generic, on 1,623 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
1,623
Total Claims
$89K
Total Drug Cost
847
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,694
- Total Day Supply
- 24,090
- Brand vs Generic
- 16% brand / 84% generic
- Brand Drug Cost
- $62K
- Generic Drug Cost
- $27K
- Opioid Claims
- 75 (4.6% rate)
- Antibiotic Claims
- 201
Patient Demographics
- Average Patient Age
- 75.8 years
- Avg HCC Risk Score
- 1.11
- Gender Split
- 66% female / 34% male
- Age Distribution
- <65: 28, 65-74: 367, 75-84: 336, 85+: 116
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Michael Gingold, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Neomycin-Polymyxin…
Neomycin-Polymyxin-Dexameth
574 claims
- Erythromycin
Erythromycin
499 claims
- Cephalexin 158
Cephalexin
158 claims
- Tobramycin-Dexamet… 88
Tobramycin-Dexamethasone
88 claims
- Acetaminophen-Code… 70
Acetaminophen-Codeine
70 claims
- Moxifloxacin 51
Moxifloxacin
51 claims
- Xiidra 27
Xiidra
27 claims
- Doxycycline Hyclate 14
Doxycycline Hyclate
14 claims
| Drug | Claims |
|---|---|
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 574 |
| Erythromycin Erythromycin Base | 499 |
| Cephalexin | 158 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 88 |
| Acetaminophen-Codeine Acetaminophen With Codeine | 70 |
| Moxifloxacin Moxifloxacin Hcl | 51 |
| Xiidra Lifitegrast | 27 |
| Doxycycline Hyclate | 14 |
| Ciprofloxacin Hcl | 13 |
| Lotemax Loteprednol Etabonate | 12 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Ophthalmology Physician Overview
How Michael Gingold, M.D. fits within the Ophthalmology Physician landscape nationally.
22,082
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider
Michael Gingold, M.D.'s 1,623 claims are above the specialty average of 1,420.
Nearby Ophthalmology Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as Gingold.
Dr. Michael Abrams
M.D.
Danbury, CT
Dr. Marcio Abreu
M.D.
Bridgeport, CT
Dr. Bruce Altman
M.D.
Danbury, CT
Dr. Laura Andrews
MD
Waterbury, CT
Shimy Apoorva
Waterbury, CT
Compare Ophthalmology Physician nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Connecticut medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Connecticut
Frequently Asked Questions
What is Michael Gingold, M.D.'s specialty? ▼
Michael Gingold, M.D. specializes in Ophthalmology Physician and practices in Farmington, Connecticut. Credentials: M.D..
How much does Michael Gingold, M.D. prescribe under Medicare Part D? ▼
In 2023, Michael Gingold, M.D. wrote 1,623 Medicare Part D claims totaling $89K in drug costs for 847 beneficiaries.
What is Michael Gingold, M.D.'s Medicare quality score? ▼
Michael Gingold, M.D. has a CMS MIPS Final Score of 98.2/100 (Quality: 96.4). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Michael Gingold, M.D. located? ▼
Michael Gingold, M.D. is located at 499 FARMINGTON AVE, Farmington, CT, 06032. Phone: (860) 678-0202.
What is Michael Gingold, M.D.'s NPI number? ▼
Michael Gingold, M.D.'s National Provider Identifier (NPI) is 1275581621, issued on 05/05/2006.
Does Michael Gingold, M.D. prescribe more brand-name or generic drugs? ▼
Michael Gingold, M.D.'s prescribing is 16% brand-name and 84% generic drugs by claim count, with $62K in brand drug costs.
Does Michael Gingold, M.D. prescribe opioids? ▼
Yes, Michael Gingold, M.D. had 75 opioid claims in 2023 with an opioid prescribing rate of 4.6%.
How many Ophthalmology Physician providers are there in the US? ▼
There are 22,082 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does Michael Gingold, M.D. prescribe most often? ▼
Based on 2023 Medicare Part D data, Michael Gingold, M.D.'s most frequently prescribed drugs include Neomycin-Polymyxin-Dexameth, Erythromycin, Cephalexin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Michael Gingold, M.D. accept Medicare? ▼
Michael Gingold, M.D. appears in CMS Medicare data with 1,623 Part D claims and 847 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Michael Gingold, M.D.'s credentials? ▼
Michael Gingold, M.D.'s NPI is 1275581621 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.